Skip to content

evaluation of 2% chlorexidine in root canal treatment in primary teeth

Evaluation of chlorhexidine 2% in pulp therapy for primary teeth with pulp necrosis

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
REBEC
Registry ID
RBR-9y73dr
Enrollment
Unknown
Registered
2015-12-02
Start date
2015-03-19
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

necrotic pulp in primary teeth

Interventions

The control group will be held pulpectomy in 15 primary teeth using standard irrigation of 1% sodium hypochlorite and delay healing and filling with calcium hydroxide in propylene glycol. Group test:
Procedure/surgery

Sponsors

Faculdade de Odontologia da Universidade Federal do Rio Grande do Sul
Lead Sponsor
Centro Universitário Franciscano
Collaborator

Eligibility

Age
5 Years to 10 Years

Inclusion criteria

Inclusion criteria: Children 5 to 10 years who have at least one primary molar with pulp necrosis and indication pulpectomy.

Exclusion criteria

Exclusion criteria: indication for extraction during the endodontic procedure; impossibility of collecting the microbiological root canal.

Design outcomes

Primary

MeasureTime frame
The outcome is evaluated the clinical success of the treatment. Success will be determined by evaluating the number of teeth with regression of signs and symptoms of pulp necrosis during the monitoring period. Signs and symptoms of necrotic pulp will be analyzed: spontaneous pain, swelling, fistula, mobility not compatible in root resorption stage and bone thinning observed by radiographic examination.

Secondary

MeasureTime frame
The outcome will be analyzed microbial reduction. It will be determined that the number of teeth have no microbial contamination after treatment.

Countries

Brazil

Contacts

Public ContactLuciano Casagrande

Faculdade de Odontologia da Universidade Federal do Rio Grande do Sul

luciano.casagrande@hotmail.com55(51)33085010

Outcome results

None listed

Source: REBEC (via WHO ICTRP)